A clinical trial to study the efficacy of homoeopathic medicine Prunus spinosa in treatment of Migraine in age group of 20-50 years.

Efficacy of Homoeopathic medicine Prunus spinosa 30 CH in treatment of Migraine in 20 - 50 years age groups.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/06/034085

Enrollment

Registered

2021-06-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Homoeopathic medicine Prunus spinosa 30CH: Potentised homoeopathic medicine 30CH in the form of pills or powder. Dose - administration of Prunus spinosa 30CH is based on therapeutic pre

Eligibility

Inclusion criteria

Inclusion criteria: 1. Those cases fulfilling the International Headache Society, diagnostic criteria for Migraine. 2. Patients of both sexes will be included in the study. 3. Patients of 20-50 years of age groups of various socioeconomic groups will be included. 4. Patient without any other systemic diseases. 5. Patient giving written consent form.

Exclusion criteria

Exclusion criteria: 1. That doesnâ??t fulfill the International Headache Society, diagnostic criteria for Migraine. 2. Cases with a serious complication of MIGRAINE. 3. Patients with Psychiatric diagnosis. 4. Pregnant and lactating women. 5. Malignancy cases. 6. Recent major surgery. 7. Immunocompromised cases. 8. Patients requiring emergency medical care. 9. Patients who have participated in any other Research study in the last 6 months. 10. Those under other medications. Or using any other medicine during the study period.

Design outcomes

Secondary

Measure	Time frame
Reduce attack frequency, severity, and duration of Migraine.Timepoint: 1. First follow-up will be on the 7th day of starting the treatment. 2. Second, follow-up and onward will be after 15 days and according to the need of the patient.	—

Primary

Measure	Time frame
To know the possible effects of Prunus spinosa 30 CH in patients with migraine in usual care before and after treatment.Timepoint: 1. It will be assessed on first day of treatment after that first follow-up will be on the 7th day of starting the treatment. 2. Second, follow-up and onward will be after 15 days and according to the need of the patient.	—

Countries

India

Contacts

Public ContactDr Dheeraj Pandey

Bharati Vidyapeeth Deemed to be University Pune

dranilpatil5258@gmail.com9890818201

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026